术前中性粒细胞与淋巴细胞比值预测HPV相关口咽癌经口机器人手术后复发
单机构回顾性研究纳入117例HPV阳性口咽鳞癌患者,评估术前中性粒细胞与淋巴细胞比值(NLR)对经口机器人手术(TORS)后生存结局的预测作用。
要点
- 术前NLR>2.2与HPV+口咽癌TORS术后无复发生存降低独立相关。
- NLR>2.2对总生存无显著影响,仅预测复发风险。
- NLR可能作为补充性风险分层生物标志物用于前瞻性试验。
核心结论
- 术前NLR>2.2可独立预测HPV+口咽鳞癌患者TORS术后更差的无复发生存,但总生存无显著差异。
主要发现
- 117例患者中85.5%为男性,94.0%为白人,平均年龄59.6±9.1岁;13例(11.1%)复发,中位复发时间23.5±23个月,其中7例远处转移;末次随访时90.6%存活。
关键数值与推荐
- 术前NLR计算基于手术前1个月内采集的全血细胞计数。
- NLR>2.2被确定为预测无复发生存更差的阈值。
临床怎么用
- 对于接受TORS的HPV+口咽鳞癌患者,术前NLR>2.2可提示复发风险增高,或可辅助术后风险分层和随访策略制定。
局限性
- 单机构回顾性设计,样本量有限(117例),复发事件较少(13例),结果需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluate the role of preoperative neutrophil-to-lymphocyte ratio (NLR) as a predictor of survival outcomes after transoral robotic surgery (TORS) for human papillomavirus-related (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). STUDY DESIGN: Single-institution retrospective review of patients who underwent TORS for HPV + OPSCC from April 2014 to October 2021 and had a preoperative complete blood count test. SETTING: Tertiary academic center. METHODS: Preoperative NLR was calculated from complete blood counts drawn within 1 month prior to surgery. Receiver operating characteristic curves evaluated performance of prognostic markers. Kaplan-Meier estimator and Cox regression analyses were used to evaluate survival outcomes when controlling for confounding variables. RESULTS: A total of 117 patients were included (85.5% male, 94.0% Caucasian, 59.6 ± 9.1 years old), of which 13 patients (11.1%) recurred at a median of 23.5 ± 23 months, including 7 distant metastases. At the latest follow-up, 90.6% remained alive. On Kaplan-Meier analyses, a preoperative NLR of >2.2 was associated with worse recurrence-free survival (77.1% vs 95.5%, P = .02), whereas overall survival was similar between patients (P = .94). When controlling for demographics, tumor stage, pathologic risk criteria, and adjuvant therapy, NLR > 2.2 remained a significant independent predictor of recurrence on multivariate Cox regression analysis (HR 20.6, 95% CI 1.92-80.7, P = .012). CONCLUSION: While OS was similar across groups, a preoperative NLR of >2.2 predicted worse recurrence-free survival in a cohort of patients with HPV + OPSCC who underwent TORS. Future studies may consider integrating NLR into prospective trials as a complementary risk-stratification biomarker.
引用
- Harris MK, Daniels K, Helou V, et al. Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence in HPV-Associated Oropharyngeal Cancer After Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2026. PMID: 42371658. doi:10.1002/ohn.70328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。